The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate cancer (NRG PROMETHEAN).
 
Bridget F. Koontz
Consulting or Advisory Role - Blue Earth Diagnostics; Rythera Therapeutics
Research Funding - Blue Earth Diagnostics (Inst); Janssen Medical Affairs (Inst); Merck (Inst); Rythera Therapeutics (Inst)
 
Theodore Karrison
No Relationships to Disclose
 
Thomas Michael Pisansky
No Relationships to Disclose
 
Edwin Melencio Posadas
Consulting or Advisory Role - Bayer; CytoLumina; Myovant Sciences
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
 
Leslie K. Ballas
Employment - Cedars-Sinai
Consulting or Advisory Role - Pfizer/Astellas
 
Alejandro Berlin
Consulting or Advisory Role - Abbvie; Astellas Pharma; Ferring
Research Funding - Abbvie
 
William A. Hall
Consulting or Advisory Role - Aktis Oncology
Research Funding - Elekta (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Health; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Jennifer C O'Daniel
Employment - PVerify (I)
Leadership - PVerify (I)
 
Thomas A. Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Lantheus Medical Imaging (Inst); Philips Healthcare (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Joseph P. Rodgers
No Relationships to Disclose
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics